Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods

Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods

US Patent 7081470 · Granted Jul 25, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety2012
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety2012
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety2012
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety2011
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety2011
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety2011
Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds 2008
3-imino-2-indolones for the treatment of depression and/or anxiety2007
3-imino-2-indolones for the treatment of depression and/or anxiety2007
Compounds specific for the human &agr;1d adrenergic receptor and uses thereof2004